Part of the CIEN team dedicated to the SCAP-AD Project, with José Luis and Aguas, volunteers 1,000 and 1,001 respectively.
News
SCAP-AD Project Achieves Recruitment Goals and Advances Strongly Toward Early Detection of Alzheimer’s Disease
)
)
)
The SCAP-AD Project (Cognitive Screening and Personalized Approach for Alzheimer’s and Other Dementias), coordinated by the CIEN Center for Neurological Disease Research, closes the year having fully achieved the recruitment targets set for 2025. This milestone reflects the commitment of the 13 participating centers and the strong response from the public to this leading research initiative.
The continuous work of the CIEN team and the involvement of the community have made it possible to recruit over six hundred volunteers at CIEN alone, and more than four hundred from ACE Alzheimer Center Barcelona, demonstrating the strong participation the project is generating across all involved centers. These numbers represent only a part of the overall progress of the project, which continues to grow thanks to the combined effort of all teams.
SCAP-AD, which combines a digital cohort open to the general population with a more comprehensive clinical validation cohort, is establishing itself as an innovative model for the early detection of cognitive decline and the development of precision medicine tools applied to Alzheimer’s disease.
This project (PMP22/00022) has been funded by the Instituto de Salud Carlos III with support from the European NextGenEU funds, which finance actions under the Recovery and Resilience Mechanism.
Acknowledgements
CIEN would like to express its sincere gratitude:
- To all the volunteers, for their generosity, time, and trust in research.
- To the participating centers, whose commitment and coordination have been essential in reaching this milestone.
- To the CIEN team, for their dedication, rigor, and continuous effort in driving the project forward.
- To the funding entities, including the Instituto de Salud Carlos III and the European NextGenEU funds, whose support makes it possible for innovative projects like SCAP-AD to develop and contribute to improving the early detection of Alzheimer’s disease.
The progress of SCAP-AD is a collective achievement. Thanks to the support of all who participate, collaborate, and fund research, we continue moving toward a future where early detection of Alzheimer’s disease is more precise, accessible, and effective.